TLRY trades 111.4% below Wall Street's consensus target of $10.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes TLRY achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 20 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Tilray Brands, Inc. (TLRY) has a Wall Street consensus price target of $10.00, based on estimates from 20 covering analysts. With the stock currently trading at $4.73, this represents a potential upside of +111.4%. The company has a market capitalization of $551M.
Analyst price targets range from a low of $10.00 to a high of $10.00, representing a 0% spread in expectations. The median target of $10.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, TLRY trades at a trailing P/E of -0.1x. Analysts expect EPS to grow +97.7% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CGCCanopy Growth Corporation | $372M | $0.97 | $14.47 | +1396.1% | Hold | — | 26 |
CRONCronos Group Inc. | $1.0B | $2.71 | $2.30 | -15.1% | Hold | 31.0x | 15 |
ACBAurora Cannabis Inc. | $181M | $2.93 | $5.92 | +102.0% | Hold | — | 14 |
SMGThe Scotts Miracle-Gro Company | $3.8B | $64.69 | $72.25 | +11.7% | Buy | 14.9x | 17 |
IIPRInnovative Industrial Properties, Inc. | $1.7B | $59.60 | $84.67 | +42.1% | Hold | 13.9x | 11 |
HYFMHydrofarm Holdings Group, Inc. | $4M | $0.91 | — | — | — | — | — |
LWAYLifeway Foods, Inc. | $389M | $25.43 | $35.00 | +37.6% | Buy | 22.9x | 7 |
STZConstellation Brands, Inc. | $24.5B | $141.18 | $178.11 | +26.2% | Buy | 12.0x | 46 |
BUDAnheuser-Busch InBev SA/NV | $138.9B | $80.74 | $89.00 | +10.2% | Buy | 18.4x | 45 |
SAMThe Boston Beer Company, Inc. | $1.9B | $176.11 | $242.25 | +37.6% | Hold | 18.5x | 31 |
Quick answers to the most common questions about buying TLRY stock.
The consensus Wall Street price target for TLRY is $10, representing 111.4% upside from the current price of $4.73. With 20 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
TLRY has a consensus rating of "Hold" based on 20 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $10 implies 111.4% upside from current levels.
TLRY's current price is $4.73 with a consensus target of $10 (111.4% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $10 for TLRY, while the most conservative target is $10. The consensus of $10 represents the median expectation. These targets typically reflect 12-month expectations.
TLRY is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 13 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TLRY stock forecast based on 20 Wall Street analysts shows a consensus price target of $10, with estimates ranging from $10 (bear case) to $10 (bull case). The median consensus rating is "Hold".
Wall Street analysts are very optimistic on TLRY, with a "Hold" consensus rating and $10 price target (111.4% upside). 5 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TLRY analyst price targets range from $10 to $10, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.